Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations.

CONCLUSIONS: The prevalence of CALR mutation in JAK2V617F-negative ET in this study is 35.7%. HRM is an effective method of detecting CALR mutation and is a more advantageous method of screening for CALR mutation. PMID: 29521158 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29521158?dopt=Abstract

Source: Hematology - March 11, 2018 Category: Hematology Tags: Hematology Source Type: research

More News: Hematology | Study